Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|October 4, 2011
Emerging options in growth hormone therapy: an updateStephen F Kemp, J Paul Frindik
Biologics : Targets & Therapy|July 16, 2010
Managing idiopathic short stature: role of somatropin (rDNA origin) for injectionJ Paul Frindik, Stephen F Kemp
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 11, 2003
Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiencyJ Paul Frindik, Stephen F Kemp, J J Hunold
Diabetes Technology & Therapeutics|July 2, 2011
Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetesKathryn M Thrailkill, Cynthia S Moreau, Christopher Swearingen, et al.
Diabetes Care|June 15, 2007
Matrix metalloproteinase-2 dysregulation in type 1 diabetesKathryn M Thrailkill, Robert C Bunn, Cynthia S Moreau, et al.
The American Journal of Medicine|August 7, 2007
Office approach to anaphylaxis: sooner better than laterStephen F Kemp
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 19, 2005
Growth hormone treatment of idiopathic short stature: history and demographic data from the NCGSStephen F Kemp
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2007
Mecasermin rinfabateStephen F Kemp
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 25, 2009
Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment optionsStephen F Kemp
Pageof 4